Leccese A P, Marquis K L, Mattia A, Moreton J E
Behav Brain Res. 1986 Dec;22(3):257-64. doi: 10.1016/0166-4328(86)90070-7.
The effects of chronic phencyclidine (PCP) or ketamine (KET) on their respective acute behavioral and anticonvulsant actions were investigated. Female rats were treated for 15 days with twice daily i.p. injections of saline, 20 mg/kg PCP or 40 mg/kg KET. Subjects treated chronically with PCP were challenged with either 10 mg/kg or 20 mg/kg i.p. PCP, while subjects treated chronically with KET were challenged with 40 mg/kg i.p. KET only. Neither chronic drug treatment induced tolerance to the acute anticonvulsant effect, nor to hyperlocomotion and stereotypy as measured by automated activity monitors. However, evidence of tolerance to the stereotypy induced by acute KET was obtained when an observer-based rating scale was employed. In addition, tolerance occurred to the ataxia induced by KET and the 10 mg/kg, but not 20 mg/kg, dose of PCP. Thus, tolerance occurs to some of the acute behavioral effects of PCP and KET while the anticonvulsant action of these compounds remains unaffected.
研究了慢性给予苯环己哌啶(PCP)或氯胺酮(KET)对它们各自急性行为和抗惊厥作用的影响。雌性大鼠每天腹腔注射生理盐水、20mg/kg PCP或40mg/kg KET,连续注射15天。长期接受PCP治疗的大鼠分别腹腔注射10mg/kg或20mg/kg PCP进行激发试验,而长期接受KET治疗的大鼠仅腹腔注射40mg/kg KET进行激发试验。无论是哪种慢性药物治疗,均未诱导对急性抗惊厥作用的耐受性,也未诱导对自动活动监测仪所测量的运动亢进和刻板行为的耐受性。然而,当采用基于观察者的评分量表时,发现对急性KET诱导的刻板行为产生了耐受性。此外,对KET和10mg/kg(而非20mg/kg)剂量的PCP诱导的共济失调产生了耐受性。因此,对PCP和KET的一些急性行为效应产生了耐受性,而这些化合物的抗惊厥作用未受影响。